About Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Galapagos NV
3
Camurus AB
2
Crinetics Pharmaceuticals Inc.
2
Ionis Pharmaceuticals, Inc.
2
Pfizer
2
Amgen
1
Boston Pharmaceuticals
1
EMD Serono Research & Development Institute, Inc.
1
Neovacs
1
Clinical Trials at Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o.
During the past decade, Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o. conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on
average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)
2013-07-17
2015-05-14
Completed
599
Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2)
2013-10-08
2015-05-29
Completed
287
Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid Arthritis
2013-09-01
2014-09-01
Completed
143
Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Patients
2014-02-25
2023-01-19
Completed
739
Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care
2018-01-10
2020-11-26
Completed
143
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands
2018-09-13
2021-04-02
Completed
43
Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
2018-06-29
2019-08-13
Completed
391
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o." #1 sponsor was "Galapagos NV" with 3 trials, followed by "Camurus AB" with 2 trials
sponsored, "Crinetics Pharmaceuticals Inc." with 2 trials sponsored, "Ionis Pharmaceuticals, Inc." with 2 trials sponsored and "Pfizer"
with 2 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o."
#1 collaborator was "Gilead Sciences" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o.
According to Clinical.Site data, the most researched conditions in "Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o." are
"Acromegaly" (6 trials), "Rheumatoid Arthritis" (4 trials), "Dermatitis, Atopic" (2 trials), "Systemic Lupus Erythematosus" (2 trials) and "Plaque Psoriasis" (1 trials). Many other conditions were trialed in "Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o." in a lesser frequency.
Clinical Trials Intervention Types at Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o.
Most popular intervention types in "Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o." are "Drug" (14 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "CAM2029 (octreotide subcutaneous depot)" (2 trials), "GLPG0634" (2 trials), "Paltusotine" (2 trials) and "ABP 501" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o.
The vast majority of trials in "Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o." are
15 trials for "All" genders.
Clinical Trials Status at Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o.
Currently, there are NaN active trials in "Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o.".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o., 1 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".